Fighting the risk of developing Parkinson's disease; Clinical counseling for first degree relatives of patients with Parkinson's disease

Journal of the Neurological Sciences

Volumn 310, Issue 1-2, 2011, Pages 17-20

  Giladi, Nir ^a   Mirelman, Anat ^a,b   Thaler, Avner ^a   Bar Shira, Anat ^a   Gurevich, Tanya ^a   Orr Urtreger, Avi ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Clinical counseling; LRRK2 gene; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; ARTICLE; AWARENESS; BEHAVIOR CHANGE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; INFORMATION; ISRAEL; MALE; MOTOR SYSTEM; PARKINSON DISEASE; POPULATION; PRIORITY JOURNAL; PROGENY; RELATIVE; SIBLING; SYMPTOM;

ADULT; CROSS-SECTIONAL STUDIES; FAMILY; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; ISRAEL; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; REFERRAL AND CONSULTATION; RISK;

EID: 80054102810     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.06.005     Document Type: Article

References (30)

1. E. Bezard, C. Imbert, and C.E. Gross Experimental models of Parkinson's disease: from the static to the dynamic Rev Neurosci 9 2 1998 71 90 (Pubitemid 28386640)
2. A. Siderowf, and M.B. Stern Premotor Parkinson's disease: clinical features, detection, and prospects for treatment Ann Neurol 64 Suppl 2 2008 Dec S139 S147
3. E.C. Wolters, C. Francot, and P. Bergmans Preclinical (premotor) Parkinson's disease J Neurol 247 Suppl 2 2000 Apr II103 II109
4. Y. Wu, W. Le, and J. Jankovic Preclinical biomarkers of Parkinson disease Arch Neurol 68 1 2011 Jan 22 30
5. L.N. Clark, Y. Wang, and E. Karlins Frequency of LRRK2 mutations in early- and late-onset Parkinson disease Neurology 67 10 2006 Nov 28 1786 1791 (Pubitemid 44900754)
6. L.N. Clark, B.M. Ross, and Y. Wang Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease Neurology 69 12 2007 Sep 18 1270 1277 (Pubitemid 47429028)
7. A. Orr-Urtreger, C. Shifrin, and U. Rozovski The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Neurology 69 16 2007 Oct 16 1595 1602 (Pubitemid 350287143)
8. L.J. Ozelius, G. Senthil, and R. Saunders-Pullman LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews N Engl J Med 354 4 2006 Jan 26 424 425 (Pubitemid 43145083)
9. D.P. Breen, A.W. Michell, and R.A. Barker Review: Parkinson's disease - the continuing search for biomarkers Clin Chem Lab Med 49 3 2011 Mar 393 401 Feb 3
10. Blog Sergey Brin's Internet Communication http://too.blogspot.com/ 2011
11. Z. Gan-Or, N. Giladi, and A. Orr-Urtreger Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations Brain 132 Pt 10 2009 Oct e125
12. E. Sidransky, M.A. Nalls, and J.O. Aasly Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease N Engl J Med 361 17 2009 Oct 22 1651 1661
13. P. Martinez-Martin, A. Gil-Nagel, L.M. Gracia, J.B. Gomez, J. Martinez-Sarries, and F. Bermejo Unified Parkinson's Disease Rating Scale characteristics and structure The Cooperative Multicentric Group. Mov Disord 9 1 1994 Jan 76 83 (Pubitemid 24022618)
14. R.L. Doty, P. Shaman, and M. Dann Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function Physiol Behav 32 3 1984 Mar 489 502 (Pubitemid 14148126)
15. R.L. Doty, P. Shaman, C.P. Kimmelman, and M.S. Dann University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic Laryngoscope 94 2 Pt 1 1984 Feb 176 178 (Pubitemid 14186660)
16. M.J. Forjaz, A. Ayala, C. Rodriguez-Blazquez, B. Frades-Payo, and P. Martinez-Martin Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis Eur J Neurol 17 2 2010 Feb 273 279
17. S.X. Li, Y.K. Wing, and S.P. Lam Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK) Sleep Med 11 1 2010 Jan 43 48
18. D.J. Brooks Imaging dopamine transporters in Parkinson's disease Biomark Med 4 5 2010 Oct 651 660
19. D.J. Brooks, and N. Pavese Imaging non-motor aspects of Parkinson's disease Prog Brain Res 184 2010 205 218
20. K. Singh, S. Singh, N.K. Singhal, A. Sharma, D. Parmar, and M.P. Singh Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism Chem Biol Interact 185 2 2010 Apr 29 81 93
21. K. Trinh, L. Andrews, and J. Krause Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson's disease through an NRF2-dependent mechanism J Neurosci 30 16 2010 Apr 21 5525 5532
22. J. Costa, N. Lunet, C. Santos, J. Santos, and A. Vaz-Carneiro Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies J Alzheimers Dis 20 Suppl 1 2010 S221 S238
23. R.A. Popat, S.K. Van Den Eeden, and C.M. Tanner Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease Eur J Neurol 2011 Jan 31 [Epub ahead of print]
24. L. Aitlhadj, D.S. Avila, A. Benedetto, M. Aschner, and S.R. Sturzenbaum Environmental exposure, obesity, and Parkinson's disease: lessons from fat and old worms Environ Health Perspect 119 1 2011 Jan 20 28
25. H. Chen, T.H. Mosley, A. Alonso, and X. Huang Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study Am J Epidemiol 169 9 2009 May 1 1064 1069
26. X. Gao, H. Chen, H.K. Choi, G. Curhan, M.A. Schwarzschild, and A. Ascherio Diet, urate, and Parkinson's disease risk in men Am J Epidemiol 167 7 2008 Apr 1 831 838 (Pubitemid 351451751)
27. P. Knekt, A. Kilkkinen, H. Rissanen, J. Marniemi, K. Saaksjarvi, and M. Heliovaara Serum vitamin D and the risk of Parkinson disease Arch Neurol 67 7 2010 Jul 808 811
28. X. Gao, H. Chen, M.A. Schwarzschild, and A. Ascherio Use of ibuprofen and risk of Parkinson disease Neurology 76 10 2011 Mar 8 863 869
29. B. Ritz, S.L. Rhodes, L. Qian, E. Schernhammer, J.H. Olsen, and S. Friis L-type calcium channel blockers and Parkinson disease in Denmark Ann Neurol 67 5 2010 May 600 606
30. D.J. Surmeier Calcium, ageing, and neuronal vulnerability in Parkinson's disease Lancet Neurol 6 10 2007 Oct 933 938 (Pubitemid 47405004)